Search

Your search keyword '"Ramón Corbalán"' showing total 308 results

Search Constraints

Start Over You searched for: Author "Ramón Corbalán" Remove constraint Author: "Ramón Corbalán"
308 results on '"Ramón Corbalán"'

Search Results

1. Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF

3. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54

5. Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial

6. La llum, vista a través de l’electrodinàmica quàntica

7. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

8. Bernard Lown y El Arte de Sanar

9. GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

10. Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.

11. Preoperative soluble VCAM‐1 contributes to predict late mortality after coronary artery surgery

12. Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group

13. Autophagy in the cardiovascular system

14. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54

15. Manejo de hemorragia asociada a anticoagulantes orales directos: estado actual de las estrategias de reversión

16. VCAM-1 as a predictor biomarker in cardiovascular disease

17. Optimizing Treatment for Acute Myocardial Infarction, a Continuous Effort

18. La llum, vista a través de l'electrodinàmica quàntica

19. Polarization phase gate with a tripod atomic system

20. Competition and bistability of longitudinal modes in a Raman laser

21. Full polarization chaos in a pump-polarization modulated isotropic cavity laser

22. Ultrashort pulse control of space-dependent excitations in a three-level system

23. Antiplatelet Therapy And Percutaneous Coronary Interventions

24. Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF

25. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials

26. Cardiorespiratory fitness improves prediction of mortality of standard cardiovascular risk scores in a Latino population

27. Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation

28. Increased C-reactive protein plasma levels are not involved in the onset of post-operative atrial fibrillation

29. Características basales, manejo de terapias antitrombóticas y pronóstico de pacientes chilenos con FA no valvular. Lecciones del Registro GARFIELD AF en Chile

30. Implante percutáneo de válvula aórtica con apoyo de circulación extracorpórea en paciente con insuficiencia aórtica severa

31. Impacto de un programa de rehabilitación cardiovascular fase II sobre la calidad de vida de los pacientes

32. Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial

33. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

34. Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial

35. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction

36. Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)

37. Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes

38. Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients

39. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54

40. [Management of bleeding associated with direct oral anticoagulants: update on reversal strategies]

41. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

42. Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack

43. Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

45. [Features, management and prognosis of Chilean patients with non valvular atrial fibrillation: GARFIELD AF registry]

46. Strain auricular izquierdo y biomarcadores cardíacos como predictores de accidente cerebrovascular en pacientes con fibrilación auricular de reciente comienzo

47. Rehabilitación cardiovascular y ejercicio en prevención secundaria

48. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry

49. Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis

50. ¿Sirven los marcadores de riesgo no tradicionales en la diferenciación del riesgo cardiovascular en adultos jóvenes con exceso de peso?

Catalog

Books, media, physical & digital resources